01 February 2018 The Ardonagh Group announces that its Board has approved the appointment of Matt Raino as an Investor Director on the Board. This appointment has received regulatory approval. Matt Raino Matt joins The Ardonagh Group Board as an Investor representative of Madison Dearborn...
11 January 2018 The Ardonagh Group (“Ardonagh” or “the Group”) today announces that David Newman is to step down as CEO of Carole Nash. David will remain with the business until the end of March 2018. Ian Donaldson will be appointed CEO of Carole Nash*,...
The Ardonagh Group (“the Group”) today announces the appointment of Iain Laws as CEO Healthcare. Iain, who will join the Group in January 2018, will lead Healthcare, bringing together Towergate Health and Chase Templeton and will report into Rob Worrell, CEO Insurance Broking. Iain has...
The Ardonagh Group today announces the appointment of Janice Deakin as Deputy CEO*, with immediate effect. Janice will continue to lead Distribution as CEO of that segment, a role she has held since the creation of Ardonagh in June 2017. During that time she has...
The Ardonagh Group announces that Daniel Pietrzak and Oliver Feix have resigned as Investor Directors of The Ardonagh Group and that its Board has approved the appointments of Matthieu Boulanger and Aurelio Cusaro as Investor Directors in their place. Both appointments are subject to regulatory...
The Ardonagh Group (“the Group”) today announces the appointment of Michael Donegan as Strategic Adviser. Michael will step away from the day-to-day operations of Price Forbes, where he has been CEO since 2004. The Group today also announces the appointment of James Masterton as CEO...
Company number: 13789356, incorporated in England and Wales.
Registered address: 2 Minster Court, Mincing Lane, London, EC3R 7PD
